NCT02410317View on ClinicalTrials.gov

Ropivacaine Through Continuous Infusion Versus Epidural Morphine for Postoperative Analgesia After Emergency Cesarean Section

PHASE3CompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

February 28, 2015

Primary Completion Date

August 28, 2021

Study Completion Date

December 28, 2021

Conditions
Postoperative Pain
Interventions
DRUG

Ropivacaine

DRUG

Morphine

Trial Locations (1)

Unknown

Hôpital Couple Enfant - CHU de Grenoble, Grenoble

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT02410317 - Ropivacaine Through Continuous Infusion Versus Epidural Morphine for Postoperative Analgesia After Emergency Cesarean Section | Biotech Hunter | Biotech Hunter